Blueprint Health

Blueprint Health was a highly influential, mentorship-driven startup accelerator based in New York City, specifically focused on companies at the intersection of health and technology. Launched in 2011, it quickly established itself as a key early-stage investor and ecosystem builder within the burgeoning digital health sector. The program was designed to provide nascent health tech startups with critical resources, including seed capital, office space, and invaluable access to a vast network of healthcare executives, investors, and seasoned entrepreneurs. Its unique value proposition lay in its intensive, hands-on mentorship model, aiming to accelerate the growth and market readiness of its portfolio companies.

Historically, Blueprint Health's accelerator program typically involved an investment of between $20,000 and $50,000 in exchange for a fixed equity stake, commonly around 6%. This capital was coupled with a structured, often three-month, curriculum that guided founders through product development, market validation, and fundraising strategies. Over its active period, Blueprint Health made a significant impact, investing in over 100 companies, fostering a vibrant community of innovators, and helping many secure follow-on funding from larger venture capital firms. Its portfolio included companies that went on to achieve notable success and acquisitions, demonstrating the effectiveness of its early-stage support.

While Blueprint Health LLC remains an entity, its core accelerator program, as it was widely known, appears to have wound down or significantly changed its operational model around 2015-2016. The organization's website is no longer active in its original form, and new accelerator cohorts have not been announced for several years. Consequently, while its historical contributions to the health tech landscape are undeniable, it is not currently an active participant in the same capacity as a recurring accelerator program making new seed investments. Prospective founders should be aware that its primary investment activity through accelerator cohorts is largely historical.